Latest Breaking News On - Jackw schuler - Page 1 : comparemela.com

Accelerate Diagnostics (AXDX) Prices $15 Million Public Offering and Private Placement of Common Stock, Warrants

Accelerate Diagnostics (AXDX) Prices $15 Million Public Offering and Private Placement of Common Stock, Warrants
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Jackw schulerDiagnostics incJackw schuler livingCraig hallum capital groupWilliam blair companyAccelerate diagnosticsLiving trust

Accelerate Diagnostics Announces Pricing of Approximately $15 Million Public Offering and Private Placement

Accelerate Diagnostics Announces Pricing of Approximately $15 Million Public Offering and Private Placement
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesRiverside plazaJackw schulerProspectus departmentWilliam blair companyExchange commissionJackw schuler livingCraig hallum capital groupPrnewswire accelerate diagnostics incDiagnostics incLiving trustWilliam blairAccelerate diagnosticsAccelerate phenoAccelerate phenotestAnnual report

Biodesix, Inc (NASDAQ:BDSX) Short Interest Update

Biodesix, Inc. (NASDAQ:BDSX – Get Free Report) was the recipient of a significant drop in short interest during the month of September. As of September 30th, there was short interest totalling 143,900 shares, a drop of 37.3% from the September 15th total of 229,600 shares. Based on an average daily volume of 78,500 shares, the […]

United statesJackw schulerEssex investment management coRenaissance technologiesVanguard group incBiodesix company profileSecurities exchange commissionCapital managementBiodesix incCi private wealthGet free reportStock downDirector jackExchange commissionEssex investment managementInvestment management

Short Interest in Yield10 Bioscience, Inc (NASDAQ:YTEN) Decreases By 26 6%

Yield10 Bioscience, Inc. (NASDAQ:YTEN – Get Free Report) was the target of a significant drop in short interest in September. As of September 30th, there was short interest totalling 131,300 shares, a drop of 26.6% from the September 15th total of 178,900 shares. Based on an average daily trading volume, of 332,800 shares, the days-to-cover […]

United statesJackw schulerBioscience company profileWealth managementMillennium managementBioscience incGet free reportStreet groupStreet capitalYield10 bioscienceNasdaq ytenConsumer staple

Yield10 Bioscience, Inc (NASDAQ:YTEN) Major Shareholder Jack W Schuler Buys 765,000 Shares

Yield10 Bioscience, Inc. (NASDAQ:YTEN – Get Free Report) major shareholder Jack W. Schuler acquired 765,000 shares of the firm’s stock in a transaction on Tuesday, August 15th. The stock was bought at an average price of $0.65 per share, with a total value of $497,250.00. Following the completion of the acquisition, the insider now directly […]

United statesJackw schulerBioscience incWealth managementSecurities exchange commissionMillennium managementGet free reportExchange commissionStreet capitalStreet groupGrand wealth managementYield10 bioscienceNasdaq ytenConsumer stapleInsider tradingNsider trades